DK234789D0 - Antistoffer mod latente human papillomavirusproteiner, diagnostiske systemer og diagnostiske metoder - Google Patents

Antistoffer mod latente human papillomavirusproteiner, diagnostiske systemer og diagnostiske metoder

Info

Publication number
DK234789D0
DK234789D0 DK234789A DK234789A DK234789D0 DK 234789 D0 DK234789 D0 DK 234789D0 DK 234789 A DK234789 A DK 234789A DK 234789 A DK234789 A DK 234789A DK 234789 D0 DK234789 D0 DK 234789D0
Authority
DK
Denmark
Prior art keywords
diagnostic
antibodies against
human papillomavirus
papillomavirus proteins
systems
Prior art date
Application number
DK234789A
Other languages
English (en)
Other versions
DK234789A (da
DK173264B1 (da
Inventor
Joakim Dillner
Richard A Lerner
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK234789D0 publication Critical patent/DK234789D0/da
Publication of DK234789A publication Critical patent/DK234789A/da
Application granted granted Critical
Publication of DK173264B1 publication Critical patent/DK173264B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK198902347A 1988-05-16 1989-05-12 Polypeptider, som reagerer med antistoffer mod latente human papillomavirusproteiner, antistoffer, som reagerer med polype DK173264B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19440788A 1988-05-16 1988-05-16
US19440788 1988-05-16
US07/323,614 US5180806A (en) 1988-05-16 1989-03-13 Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods
US32361489 1989-03-13

Publications (3)

Publication Number Publication Date
DK234789D0 true DK234789D0 (da) 1989-05-12
DK234789A DK234789A (da) 1989-11-17
DK173264B1 DK173264B1 (da) 2000-05-29

Family

ID=26889974

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198902347A DK173264B1 (da) 1988-05-16 1989-05-12 Polypeptider, som reagerer med antistoffer mod latente human papillomavirusproteiner, antistoffer, som reagerer med polype

Country Status (10)

Country Link
US (3) US5180806A (da)
EP (1) EP0344940B1 (da)
JP (1) JP2918904B2 (da)
AT (1) ATE130855T1 (da)
CA (1) CA1341287C (da)
DE (1) DE68924928T2 (da)
DK (1) DK173264B1 (da)
ES (1) ES2082775T4 (da)
GR (1) GR3018773T3 (da)
PT (1) PT90574B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9001705D0 (sv) * 1990-05-11 1990-05-11 Medscand Ab Saett foer diagnostik av virusbaerande tumoerer genom immunoassay
US5932412A (en) * 1990-05-11 1999-08-03 Euro-Diagnostica Ab Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes
DE69223844T2 (de) * 1991-04-24 1998-04-16 Morinaga Milk Industry Co Ltd Antimikrobielles Peptid und antimikrobieller Wirkstoff
EP0523391B1 (en) * 1991-07-13 2003-03-19 Dade Behring Marburg GmbH Use of HPV-16 E6 and E7-gene derived peptides for the diagnostic purpose
DE4123760C2 (de) * 1991-07-18 2000-01-20 Dade Behring Marburg Gmbh Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines
DE19819476C1 (de) * 1998-04-30 2000-01-05 Deutsches Krebsforsch Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins
GB2353581B (en) 1999-08-27 2003-06-11 Uponor Ltd Swage lining
US7026443B1 (en) * 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
JP2001172200A (ja) * 1999-12-17 2001-06-26 Meneki Seibutsu Kenkyusho:Kk ヒトナプシンａに対する抗体およびこれを用いる医薬
AU2001251394A1 (en) 2000-04-05 2001-10-23 Impact Diagnostics, Inc. Immunological methodology for discerning human papillomavirus
ES2519043T3 (es) 2000-12-08 2014-11-06 Academisch Ziekenhuis Leiden Péptidos largos de 22-45 residuos de aminoácidos que inducen y/o mejoran las respuestas inmunológicas específicas para antígenos
EP1288292A1 (en) * 2001-08-31 2003-03-05 Leids Universitair Medisch Centrum Long peptides of 22-40 amino acid residues that induce and/or enhance antigen specific immune responses.
WO2002050537A1 (en) * 2000-12-21 2002-06-27 Biosignature Diagnostics, Inc. Absorbance multiplex technology
US6933123B2 (en) 2001-04-05 2005-08-23 Yao Xiong Hu Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
GB2379220A (en) * 2001-08-13 2003-03-05 Univ York Antibodies to HPV E2 protein
ATE557099T1 (de) * 2003-09-05 2012-05-15 Genencor Int Hpv cd8+ t-zell-epitope
WO2005063286A1 (en) * 2003-12-23 2005-07-14 Arbor Vita Corporation Antibodies for oncogenic strains of hpv and methods of their use
AU2005222776A1 (en) * 2003-12-31 2005-09-29 Genimmune N.V. Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US8051950B2 (en) * 2006-08-03 2011-11-08 Glacier Bay, Inc. System for reducing acoustic energy
WO2010129821A1 (en) 2009-05-07 2010-11-11 Oncohealth Corporation Identification of high grade or ≥cin2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (hpv) and hpv-associated cancers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US8278056B2 (en) * 2008-06-13 2012-10-02 Oncohealth Corp. Detection of early stages and late stages HPV infection
AU2008269721B2 (en) * 2007-05-31 2013-01-10 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Intradermal HPV peptide vaccination
JP5933437B2 (ja) * 2009-08-26 2016-06-08 セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． Ｔ細胞ヘルプを誘発する組成物
EP2521914A4 (en) 2010-01-08 2013-07-10 Oncohealth Corp CELL-BASED HPV IMMUNOTESTS HAVE A HIGH PERFORMANCE FOR DIAGNOSIS AND SCANNING OF HPV ASSOCIATED CANCER
US20110171248A1 (en) * 2010-01-08 2011-07-14 Selecta Biosciences, Inc. Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
CN103940993A (zh) * 2013-01-23 2014-07-23 艾托金生物医药（苏州）有限公司 用于检测抗人乳头瘤病毒抗体的抗原及试剂盒和应用
JP7401312B2 (ja) * 2017-06-28 2023-12-19 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 抗ヒトパピローマウイルス（ｈｐｖ）抗原結合性タンパク質およびその使用方法
US20210046114A1 (en) * 2018-01-24 2021-02-18 The Council Of The Queensland Institute Of Medical Research Hpv immunotherapy
KR20210029280A (ko) 2018-08-02 2021-03-15 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 질환을 제거하기 위한 체크포인트-억제 항체와 상승작용하는 tlr1/2 작용제 디프로보심의 애쥬번트 효과
CA3172124A1 (en) 2020-03-26 2021-09-30 Aru NARENDRAN Uses of halogenated xanthenes in oncology and virology
US11938182B2 (en) 2020-03-26 2024-03-26 Provectus Pharmatech, Inc. Halogenated xanthenes as vaccine adjuvants
CN113512109B (zh) * 2021-03-09 2022-03-25 北京康乐卫士生物技术股份有限公司 一种抗人乳头瘤病毒31型的单克隆中和抗体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6089755A (ja) * 1983-07-01 1985-05-20 フイリツプ・ジヨン・ベア−ド 診断用試薬及びその製造法並びにそれを用いる診断法
LU85462A1 (fr) * 1984-07-11 1986-02-12 Univ Louvain Nouvelles compositions polymeres,procedes pour leur production et leurs applications
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus

Also Published As

Publication number Publication date
PT90574B (pt) 1994-09-30
JP2918904B2 (ja) 1999-07-12
US5486453A (en) 1996-01-23
US5401627A (en) 1995-03-28
ATE130855T1 (de) 1995-12-15
ES2082775T3 (es) 1996-04-01
DE68924928D1 (de) 1996-01-11
GR3018773T3 (en) 1996-04-30
DE68924928T2 (de) 1996-10-17
JPH0296593A (ja) 1990-04-09
ES2082775T4 (es) 1996-08-01
US5180806A (en) 1993-01-19
EP0344940B1 (en) 1995-11-29
PT90574A (pt) 1989-11-30
DK234789A (da) 1989-11-17
EP0344940A3 (en) 1991-11-13
EP0344940A2 (en) 1989-12-06
CA1341287C (en) 2001-08-28
DK173264B1 (da) 2000-05-29

Similar Documents

Publication Publication Date Title
DK234789A (da) Antistoffer mod latente human papillomavirusproteiner, diagnostiske systemer og diagnostiske metoder
IT1083606B (it) Contenitore particolarmente provetta per analisi o procedure immuno chomiche ed enzimatiche e procedimento per la sua fabbricazione
DE69228701D1 (de) Fragmente von Prion Proteinen.
DK101890A (da) Monoklonale antistoffer mod human interleukin-4 og hybridomaer, der producerer saadanne
DK412284D0 (da) Vacciner baseret paa membran-bundne proteiner og fremgangsmaade til fremstilling deraf
ATE161577T1 (de) Erythropoietin (epo)-peptide und dagegen gerichtete antikörper
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
NO901349L (no) Fremgangsmaate for maaling eller testing.
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
DE3887053D1 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.
NO894444L (no) Anti-fucosylceramid monoklonalt antistoff.
IT8021411A0 (it) Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione.
DK392288D0 (da) Human monoklonale antistoffer samt profylaktiske ohuman monoklonale antistoffer samt profulaktiske og terapeutiske midler mod infrektioese sygdomme,deg terapeutiske midler mod infrektioese sygdomme, dr indeholder samme som aktiv bestanddel er indeholder samme som aktiv bestanddel
DE3684223D1 (de) Monoklonale antikoerper.
DK116487A (da) Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.
ATE114818T1 (de) Immuntest zum nachweis von alpha-haloacetamiden.
DK604589A (da) Peptider, og analysesaet med indhold af saadanne forbindelser
DE3886032D1 (de) Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren.
DE3877054D1 (de) Tonerkonzentrationsermittlung.
DK698288D0 (da) Stlv-iii-relaterede polypeptider, diagnostiske systemer og bestemmelsesmetoder
DK630189D0 (da) Fremgangsmaade og diagnosesaet til paavisning af antistoffer samt vandig vaskevaeske til brug herved
DK305084D0 (da) Partikel samt fremgangsmaade til paavisning af antigener og/eller antistoffer under anvendelse af partiklen
NO903788D0 (no) Monoklonalt antistoff mot protein c.
NO900048D0 (no) Paavisningsmetoder med individ-spesifikke antistoff.
ATE50452T1 (de) Mittel zum antigen/antikoerper-nachweis.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired